TrialCancer immunology research2025

Inflammatory Stress Determines the Need for Chemotherapy in Patients with HER2-Positive Esophagogastric Adenocarcinoma Receiving Targeted Therapy and Immunotherapy.

Joseph Tintelnot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.